SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-102534
Filing Date
2021-03-31
Accepted
2021-03-31 17:20:03
Documents
3
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 6-K d116611d6k.htm 6-K 10025
2 EX-99.1 d116611dex991.htm EX-99.1 9647
3 GRAPHIC g116611g0401022738914.jpg GRAPHIC 1829
  Complete submission text file 0001193125-21-102534.txt   23483
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 450-781-0115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 21794674
SIC: 2834 Pharmaceutical Preparations